The Inhibitory Effect of Triterpenoid Glycosides Originating from Sanguisorba officinalis on Tissue Factor Activity and the Production of TNF-α

Abstract

We examined the inhibitory effects of novel triterpene glycoside compounds [ziyu-glycoside II (ZY-II) and its methyl ester (ZYM-201)], which originated from the roots of Sanguisorba officinalis L. (Rosaceae), on tissue factor (TF) activity and tumor necrosis factor (TNF)-α production. In in vitro TF activity tests, ZY-II but not ZYM-201 strongly blocked lung TF activity with an IC₅₀ value of 0.46 μM. By contrast, only ZYM-201 dose-dependently inhibited in vivo TF activity with an ED₅₀ value of 1.7 mg/kg, when orally administered. Furthermore, ZYM-201 diminished both in vitro and in vivo TNF-α production with IC₅₀ or ED₅₀ values of 69.4 μM and 87.4 mg/kg, respectively. Therefore, these results suggest either that ZYM-201 may be developed as a potent inhibitor of both TF- and TNF-α-mediated diseases such as atherosclerosis and septic shock, or it may be a lead compound to be derivatized for further improvement of its curative efficacy.

Key words

Sanguisorba officinalis L. - Rosaceae - ziyu-glycosides - ZYM-201 - tissue factor - TNF-α

References

• 1 Broze GJ J r. Tissue factor pathway inhibitor.  Thromb Haemost. 1995;  74 90-3
• 2 Kim I, Oh J L, Ryu Y S, So J N, Sessa W C, Walsh K. et al . Angiopoietin negatively regulates expression and activity of tissue factor in endothelial cells.  FASEB J. 2002;  16 126-8
• 3 Rao L V, Rapaport S I. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.  Proc Natl Acad Sci USA. 1988;  85 6687-91
• 4 Hurlimann D, Enseleit F, Ruschitzka F. Rheumatoid arthritis, inflammation, and atherosclerosis.  Herz. 2004;  29 760-8
• 5 Dang O, Navarro L, David M. Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenes.  Shock. 2004;  21 470-5
• 6 Chu A J, Walton M A, Prasad J K, Seto A. Blockade by polyunsaturated n-3 fatty acids of endotoxin-induced monocytic tissue factor activation is mediated by the depressed receptor expression in THP-1 cells.  J Surg Res. 1999;  87 217-24
• 7 Goun E A, Petrichenko V M, Solodnikov S U, Suhinina T V, Kline M A, Cunningham G. et al . Anticancer and antithrombin activity of Russian plants.  J Ethnopharmacol. 2002;  81 337-42
• 8 Liu X, Cui Y, Yu Q, Yu B. Triterpenoids from Sanguisorba officinalis .  Phytochemistry. 2005;  66 1671-9
• 9 Lee M H, Han Y N. A new in vitro tissue factor inhibitory triterpene from the fruits of Chaenomeles sinensis .  Planta Med. 2003;  69 327-31
• 10 Han Y N, Rhee I K. Changes of tissue factor activity on inflammatory stimulus and aging in rat.  Arch Pharm Res. 1998;  21 549-54
• 11 Cho J Y, Park J S, Baik K U, Lee J G, Kim H P, Yoo E S. et al . Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevent to rheumatoid arthritis.  Pharmacol Res. 2004;  49 423-31
• 12 Sommeijer D W, Hansen H R, Vano R, Hamulyak K, Vanz A P, Meesters E. et al . Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes.  J Thromb Haemost. 2005;  3 1168-71
• 13 Gorlach A. Redox regulation of the coagulation cascade.  Antioxid Redox Signal. 2005;  7 1398-404
• 14 Miller D L, Welty-Wolf K, Carraway M S, Ezban M, Ghio A, Suliman H. et al . Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide.  Am J Respir Cell Mol Biol. 2002;  26 650-8
• 15 Carmeliet P, Moons L, Dewerchin M, Mackman N, Luther T, Breier G. et al . Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system.  Ann N Y Acad Sci. 1997;  811 191-206
• 16 Yim J S, Kim Y S, Moon S K, Cho K H, Bae H S, Kim J J. et al . Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora.  Biol Pharm Bull. 2004;  27 1580-3
• 17 Cho J Y, Park J, Yoo E S, Baik K U, Jung J H, Lee J. et al . Inhibitory effect of sesquiterpene lactones from Saussurea lappa on tumor necrosis factor-alpha production in murine macrophage-like cells.  Planta Med. 1998;  64 594-7
• 18 Cho J Y, Baik K U, Jung J H, Park M H. In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa .  Eur J Pharmacol. 2000;  398 399-407
• 19 Lindmark E, Siegbahn A. Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin.  Thromb Res. 2002;  108 77-84
• 20 Camera M, Giesen P L, Fallon J, Aufiero B M, Taubman M, Tremoli E. et al . Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells.  Arterioscler Thromb Vasc Biol. 1999;  19 531-7